Advertisement
RayBiotech
RayBiotech

Research round-up

Most Recent

Chest pain and mortality

June 28, 2000

NEW YORK, June 28 (Praxis Press) Although chest pain is widely considered a key symptom of myocardial infarction (MI), not all patients with MI present with chest pain. To determine the frequency with which patients with MI present without chest pain and to examine their subsequent management and outcome, Canto and colleagues performed an observational study of patients with MI (see paper). They examined a total of 434,877 patients and evaluated mortality among MI patients without chest pain and

0 Comments

New York, June 28, 2000 (Praxis Press) Interstitial lung disease is a major cause of death in patients with systemic sclerosis (scleroderma). Studies have not precisely evaluated the association between alveolitis and lung fibrosis, and the subsequent deterioration of pulmonary function. A recent retrospective cohort study compared the outcomes of three patient groups with scleroderma lung disease: patients without alveolitis, and alveolitis patients with and without cyclophosphamide treatment a

0 Comments

GERD treatment

June 28, 2000

New York, June 28, 2000 (Praxis Press) Clinical studies showing the superiority of proton pump inhibitors over histamine-2 receptor antagonists (H2RAs) in the treatment of severe gastroesophageal reflux disease (GERD) have not been extended to patients with the milder nonerosive form of the condition, which accounts for the majority of GERD cases. According to a new study, the proton pump inhibitor lansoprazole is more effective than the H2RA ranitidine or a placebo for milder (nonerosive) form

0 Comments

PCI and elderly patients

June 28, 2000

New York, June 28, 2000 (Praxis Press) Percutaneous coronary intervention (PCI) is associated with a higher rate of related complications with elderly patients than with younger patients. Few studies however have examined the critical outcomes of this procedure on the overall health and quality of life of elderly patients. In a recent observational study Seto and colleagues found that in two clinical trials, the PCI procedure brought elderly and younger patients the same degree of improvement i

0 Comments

NEW YORK, June 28 (Praxis Press) Many treatment options are available for men with prostate cancer but therapeutic recommendations may vary depending on the type of specialist they consult. Fowler and colleagues attempted to define and contrast the distribution of prostate cancer management recommendations given by urologists and radiation oncologists (see paper). To perform the study they mailed a survey to a random sample of physicians in the United States, who were listed as urologists (respo

0 Comments

Depression and mortality

June 27, 2000

NEW YORK, June 27 (Praxis Press) Studies on whether depressive symptoms are associated with mortality in the elderly have yielded contradictory findings. To address these discrepancies, Schulz and colleagues studied a population-based sample of 5201 men and women aged 65 years and older (see paper). They examined depressive symptoms and four categories of covariates at baseline, with the primary outcome measure being mortality after six years. Of the 5201 participants, 984 (18.9%) died within 6

0 Comments

Homocysteine and CAD

June 27, 2000

NEW YORK, June 27 (Praxis Press) Circulating homocysteine levels can be used to predict survival in patients with stable coronary artery disease. The prognostic value of serum homocysteine levels, obtained in the acute phase in patients with myocardial infarction or unstable angina, however, is unknown. To test this hypothesis, Omland and colleagues measured the serum homocysteine levels of a total of 579 patients with Q-wave myocardial infarction (n=163), non- Q-wave myocardial infarction (n=21

0 Comments

NEW YORK, June 27 (Praxis Press) Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) but it is unclear whether specific COX-2 inhibitors are as effective as NSAIDs in the treatment of osteoarthritis (OA). Day and colleagues compared the efficacy and safety of the rofecoxib, which specifically inhibits COX-2, with that of the NSAID ibuprofen in 809 adult patients with OA (see paper. They found that rofecoxib was as effective as ibuprofe

0 Comments

Sigmoidoscopy discomfort

June 27, 2000

NEW YORK, June 27 (Praxis Press) Physicians often cite patient discomfort as a reason for not requesting screening flexible sigmoidoscopy. Patient experiences and attitudes toward sigmoidoscopy, however, have not been well studied. To measure patient satisfaction with screening sigmoidoscopy, Schoen and colleagues surveyed 1221 patients after sigmoidoscopy (see paper). They found that more than 93% of the participants strongly agreed or agreed they would be willing to undergo another examination

0 Comments

Thrombosis treatment

June 27, 2000

NEW YORK, June 27 (Praxis Press) Heparins have been shown to be effective and safe in the treatment of deep vein thrombosis, but the use of this treatment on an outpatient versus an inpatient basis has not been compared. To compare the two treatment locales, Boccalon and colleagues conducted a randomized, comparative, multicenter trial and evaluated the clinical outcomes and treatment costs (see paper). The researchers examined 201 patients with proximal deep vein thrombosis and administered low

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Mettler Toledo
BD Biosciences
BD Biosciences